Poll results: Preferred treatment plans for mild-stage POAG

Article

See our latest poll results

Optometry Times® polled our audience with the following question from January 28, 2022 to February 11, 2022:​ If diagnosed with mild-stage POAG, what would be your preferred treatment plan?

The poll appeared on optometrytimes.com and was promoted on social media channels. Results show the majority of responding ODs would initiate medical therapy with a topical glaucoma medication.

22 ODs responded, in total. Of these:

  • 15 responded "Initiate medical therapy with a topical glaucoma medication"
  • 4 responded "Have selective laser trabeculoplasty (SLT)"
  • 3 responded "Have a minimally invasive glaucoma surgery (MIGS)"

Check out our latest poll: What is your big goal for 2022?

Recent Videos
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Dr. Justin Schweitzer busts myths about comanaging ocular surgery
Dr. Justin Schweitzer at AAOpt
Julie Rodman, OD, MS, FAAO, discusses her Rapid Fire session on retinal diseases and conditions at AAOpt 2024
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr Nate Lighthizer discusses his 2024 Vision Expo West presentations
Jeffry Gerson, OD, FAAO, chats with Optometry Times about his talks about retina conditions at Vision Expo West
Danica Marrelli, OD, FAAO, AAO Dip, talks OCT and glaucoma
Ben Casella, OD, FAAO, talks 2024 EyeCon's networking and education opportunities
EyeCon Co-chair Oluwatosin U. Smith, MD talks passion for research and education in ophthalmology
© 2024 MJH Life Sciences

All rights reserved.